• Lazard P
  • PV 278
  • Septembre 2007


1- Barber AJ, Antonetti DA. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Invest. Ophthalmol. Vis. Sci. 2003; 44:5410-5416.
2- Bailey TA, Kanuga N, Romero IA et coll. Oxydative stress affects the junctional integrity of retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2004;45:675-684.
3- Brankin B, Campbell M, Canning P et coll. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium. Exp. Eye Res. 2005;81(1):22-31.
4- Chan-Li T, Stone J. Degeneration of astrocytes in feline retinopathy of prematurity cause failure of the blood-retinal barrier. Invest. Ophthalmol. Vis. Sci. 1992;33(7):2148-2159.
5- Chung AKH, Fung MKL, Lo ACY et coll. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina od db/db mice. Diabetes. 2005;54:3119-3125.
6- Cringle JC, Yu D-Y, Yu PK et coll. Intraretinal oxygen consumption in the rat in vivo. Invest. Ophthalmol. Vis. Sci. 2002;43(6):1922-1927.
7- Cringle JC, Yu D-Y. Intraretinal oxygenation and oxygen consumption in the rabbit during systemic hyperoxia. Invest. Ophthalmol. Vis. Sci. 2004;45(9):3223-3228.
8- Cunha-Vaz JG. The blood-retinal barrier system. Basic concepts and clinical evaluation. Exp. Eye Res. 2004;78(3):715-721.
9- Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp. Eye Res. 2005;80(2):249-258.
10- El-Remessy AB, Behzadian MA, Abou-Mohamed G et coll. Experimental Diabetes cause breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am. J. Pathol. 2003;162:1995-2004.
11- Felinsky EA, Antonetti DA. Glucocorticoid of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy. Curr. Eye Res. 2005;30(11):949-957.
12- Ferrera N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell. Physiol. 2001;280:C1358-1366.
13- Ferrera N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 2004; 25 : 581-611.
14 Gardner TW, Antonetti DA, Barber AJ et coll. Diabetic retinopathy: more than meets the eye. Sur. Ophthalmol. 2002;47(2):S253-S262.
15- Gardiner TA, Stitt AW, Anderson HR, Archer DB. Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. Br. J. Ophthalmol. 1994;78(1):54-60.
16- Gaudric A, Coscas G. Physiologie de la choroïde. Encycl. Méd. Chir. (Paris, France), Ophthalmol., 21026 D20, 11-1985, 9p.
17- Grant MB, Afzal A, Spoerri P et coll. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opin. Invest. Drugs. 2004;13(1):1275-1293.
18- Hosoya K-I, Masatoshi M. Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. Biol. Pharm. Bull. 2005;28(1):1-8.
19- NHu P, Pollard JD, Chan-Ling T. Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity. Am. J. Pathol. 2000;156:1139-1149.
20- Hui Y-N, Wu Y-Q, Xiao Q-S et coll. Repair of outer blood-retinal barrier after severe ocular blunt trauma in rabbits. Graefes's Arch. Clin. Exp. Ophthalmol. 1993;231:365-369.
21- Ida H, Tobe T, Nambu H et coll. RPE cells modulate subretinal neovascularization, but do not cause regression in mice with sustained expression of VGEF. Invest. Ophthalmol. Vis. Sci. 2003;44:5430-5437.
22- Kador PF, Takahashi Y, Wyman M et coll. Diabeteslike proliferative retinal changes in galactose-fed dogs. Arch. Ophthalmol. 1995;113(3):352-354.
23- Kador PF, Akagi Y, Terubayashi H et coll. Prevention of pericytes ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. Arch. Ophthalmol. 1988;106(8):1099-1102.
24- Kador PF, Takahashi Y, Akagi Y et coll. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs. Invest. Ophthalmol. Vis. Sci. 2002;43(6):1919-1921.
25- Kern TS, Engerman RL. Galactose-induced retinal microangiopathy in rats. Invest. Ophthalmol. Vis. Sci. 1995;36(9):490-496.
26- Koizumi K, Poulaki V, Dohemen S et coll. Contribution of TNF-? to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo. Invest. Ophthalmol. Vis. Sci. 2003;44:2184-2191.
27- Marneros AG, Fan J, Yokoyama Y et coll. Vascular endothelial growth factor in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am. J. Pathol. 2005;167:1451-1459.
28- Massin P, Paques M. Épidémiologie et physiopathologie de la rétinopathie diabétique. Encycl. Méd. Chir. (Éditions Scientifiques et Médicales Elsevier SAS, Paris), 2001, Ophtalmol., 21-240-F-10, Endocrinol.-Nutr.,10-366-K-05, 6p.
29- Moore TCB, Moore JE, Kaji Y et coll. The role of advanced glycation end products in retinal microvascular leukostsis. Invest. Ophthalmol. Vis. Sci. 2003;44:4457-4464.
30- Nambu H, Nambu R, Oshima Y et coll. Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier. Gene Ther. 2004;11(10):865-873.
31- Narayan S, Prasanna G, Krishnamoorthy RR et coll. Endothelin-1 synthesis and secretion in human retinal pigment epithelial cells (ARPE-19): differential regulation by cholinergics and TNF-alpha. Invest. Ophthalmol. Vis. Sci. 2003;44:4885-4894.
32- Neuenschwander H, Takahashi Y, Kador PF. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175. J. Ocul. Pharmacol. Ther. 1997;13(6):517-528.
33- Ota N, Tsai JY, Secchi EF, Kador PF, Sato S. Neutrophils in galactose-fed dogs: suppressed apoptosis and increased adhesion to retinal capillary endothelial cells. J. Diabetes Complications. 1999;13(3):151-158.
34- Pâques M, Massin P, Gaudric A, Vicaut E. Physiologie des vaisseaux rétiniens. Encycl. Méd. Chir. (Paris, France), Ophtalmol., 1998, 21-024-C-20.
35- Pâques M, Massin P. Facteurs de croissance angiogéniques et rétinopathie diabétique. Méd. Clin. Endocrinol. Diabète. 2002;1:18-22.
36- Pâques M, Tadayoni R, Sercombe R et coll. Structural and hemodynamic analysis of the mouse retinal microcirculation. Invest. Ophthalmol. Vis. Sci. 2003;44:4960-4967.
37- Patte M, Sillaire I, Pauchard E, Coulangeon LM et coll. Barrières hémato-oculaires. Physiologie. Encycl. Méd. Chir. (Paris, France), Ophtalmol., 2006, 21-020-D-20.
38- Peng S, Rahner C, Rizzolo L. Apical and basal regulation of the permeability of the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2003;44:808-817.
39- Sakagami K, Wu DM, Puro DG. Physiology of rat retinal pericytes: modulation of ion chanel cativity by serum-derived molecules. J. Physiol. 1999; 521(3):637-650.
40- Sato S et coll. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells. Invest. Ophthalmol. Vis. Sci. 1999;40(3):697-704.
41- Spoerri PE, Afzal A, Calzi SL et coll. Effects of VGFR-1, VGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells. Mol. Vision 2006;12:32-42.
42- Steuer H, Jaworski A, Elger B et coll. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Invest. Ophthalmol. Vis. Sci. 2005;46:1047-1053.
43- Su E, Yu D, Cringle S. Histamine induces opposing vasoactive effects at different levels of the ocular vasculature. Curr. Eye Res. 2005;30(3):205-212.
44- Tadayoni R, Paques M, Gaudric A, Vicaut E. Erythrocyte and leucocyte dynamics in the retinal capillaries of diabetic mice. Exp. Eye Res. 2003;77(4):497-504.
45- Takahashi Y, Augustin W, Wyman M, Kador P F. Quantitative analysis of retinal vessel changes in galactose-fed dogs J. Ocul. Pharmacol. 1993;9(3):257-269.
46- Tamura H, Miyamoto K, Kiryu J et coll. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest. Ophthalmol. Vis. Sci. 2005;46:1440-1444.
47- Vanhoutte PM, Félétou M. The blood vessel wall. In: EDHF, The complete story. New York,Taylor and Francis Group. 2006:1-175.
48- Xu H, Dawson R, Crane IJ, Liversidge J. Leucocytes diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier. Invest. Ophthalmol. Vis. Sci. 2005;46(7):2487-2494.
49- Xu X, Zhu Q, Xia X et coll. Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats. Curr. Eye Res. 2004;28(4):251-256.
50- Yamashiro K, Tsujikawa A, Shida S et coll. Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown. Am. J. Pathol. 2003;163:253-259.
51- Yu D-Y, Cringle ST. Low oxygen consumption in the inner retina of the visual streak of the rabbit. Am. J. Physiol. Heart Circ. Physiol. 2003;286:H419-H423.
52- Yu D-Y, Cringle SJ. Outer retinal anoxia during dark adaptation is not a general property of mammalian retinas. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2002;132(1):47-52.
53- Yu D-Y, Cringle SJ, Valter K et coll. Photoreceptor death, trophic factor expression, retinal oxygen status, and photoreceptor function in the P23H rat. Invest. Ophthalmol. Vis. Sci. 2004;45(6):2013-2019.
54- Yu D-Y, Cringle ST. Retinal degeneration and local oxygen metabolism. Exp. Eye Res. 2005;80(6):745-751.
55- Yu D-Y, Cringle SJ, Su E-R. Intraretinal oxygen distribution in the monkey retina and the response to systemic hyperoxia. Invest. Ophthalmol. Vis. Sci. 2005;46:4728-4733.
56-Yu D-Y, Cringle SJ. Oxygen distribution in the mouse retina. Invest. Ophthalmol. Vis. Sci. 2006;47(3):1109-1112.

En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...